MedTrace Logo

Investigation of the Effects of Mixed Reality Application on the Upper Extremity in Individuals With Hemiparetic Stroke

NCT07693413 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2026-07-09

No results posted yet for this study

Summary

The aim of this study is to investigate the effectiveness of mixed reality (MR)-based rehabilitation applications in improving motor functions, trunk stability, and upper extremity performance in stroke patients. The use of mixed reality technology in addition to traditional rehabilitation methods provides individuals with an interactive and motivating rehabilitation environment that mimics real-life activities. The study aims to increase functional independence, improve motor skills and trunk stability, enhance upper extremity functions, facilitate return to daily living activities, increase adaptation and motivation to the rehabilitation process, and provide a repeatable, safe, and patient-centered exercise environment in stroke patients. This thesis aims to contribute to both clinical physiotherapy practice and the literature by evaluating the applicability of mixed reality technology, a patient-centered and innovative rehabilitation approach, as a treatment option in neurological rehabilitation. The study's objective in improving upper extremity function is to make the individual less dependent on others while performing daily living activities, to instill a sense of self-sufficiency, and to enhance existing skills to make them more functional.

Conditions

Interventions

OTHER

Traditional therapy

The treatment will last 8 weeks, 3 days a week, with each session lasting 30 minutes. Participants will receive traditional physiotherapy treatment, including upper extremity strengthening, motor skills exercises, and balance exercises.

OTHER

virtual reality

The treatment will last 8 weeks, 3 days a week, with each session lasting 30 minutes. Participants will be playing Reach VR within the Meta Quest 3 using the eye.

Sponsors & Collaborators

  • Emine Ece Bedir Ayar

    lead OTHER

Principal Investigators

  • KEZBAN YİĞİTER, PROFESSOR · HASAN KALYONCU UNIVERCITY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-01
Primary Completion
2026-03-01
Completion
2026-05-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07693413 on ClinicalTrials.gov